Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma - Medical Xpress
8/11/2022 12:00:00 AM2 years 8 months ago
by Science X staff
by Science X staff
A new research paper was published in Oncotarget on August 3, 2022, entitled, "Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma."
A new research paper was published in Oncotarget on August 3, 2022, entitled, "Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma." Merkel cell … [+3040 chars]
full article...